Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
December 9, 2025The Honorable Jerry Moran, Chairman,Senate Committee on Veterans’ Affairs418 Russell Senate Office BuildingWashington, D.C. 20510The Honorable Richard Blumenthal, Ranking MemberSenate Committee on Veterans’ Affairs418 Russell Senate Office BuildingWashington, D.C. 20510Dear Senators…
The AHA supports AI policy frameworks that balance flexibility to drive market-based innovations with appropriate safeguards to protect privacy and patient safety.
AHA Nov. 5 sent a letter to the Centers for Medicare & Medicaid Services with recommendations for implementing specific provisions in the OBBBA.
The American Hospital Association (AHA) expresses support for the Home Health Stabilization Act of 2025 (H.R. 5142).
AHA and other health organizations urge Congress to protect patient access to clinical laboratory services by enacting needed reforms to the Medicare Clinical Laboratory Fee Schedule (CLFS).
The American Hospital Association (AHA) provides comments on the Office of Science and Technology Policy (OSTP) request for information regarding regulatory reform on artificial intelligence (AI).
The American Hospital Association comments on the Department of Homeland Security’s proposed weighted selection process for registrants and petitioners seeking to file cap-subject H-1B petitions.
October 23, 2025Abe Sutton, JDDeputy Administrator and DirectorCenter for Medicare and Medicaid InnovationCenters for Medicare & Medicaid Services7500 Security BlvdBaltimore, MD 21244Re: Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and…
the American Hospital Association thanks the Federal Trade Commission (FTC) for dismissing its appeals in Ryan, LLC v. FTC, No. 24-10951 (5th Cir.), and Properties of the Villages v. FTC, No. 24-13102 (11th Cir.), and acceding to the vacatur of the Non-Compete Clause Rule.
AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on personal protective equipment (PPE), medical consumables and medical equipment.